Statistics for Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer
Total visits
views | |
---|---|
Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer | 221 |
Total visits per month
views | |
---|---|
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
File Visits
views | |
---|---|
oncotarget-09-5274.pdf | 194 |
Top country views
views | |
---|---|
United States | 175 |
Germany | 12 |
Ukraine | 4 |
United Kingdom | 3 |
Bulgaria | 1 |
Canada | 1 |
Switzerland | 1 |
China | 1 |
Greece | 1 |
South Korea | 1 |
Malaysia | 1 |
Poland | 1 |
Russia | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 54 |
Fairfield | 28 |
Cambridge | 15 |
Ann Arbor | 12 |
Houston | 12 |
Kiez | 9 |
Jacksonville | 7 |
Kiev | 4 |
San Francisco | 4 |
White Plains | 4 |
Athens | 1 |
Bergheim | 1 |
Brooklyn | 1 |
Cointrin | 1 |
Columbus | 1 |
Gunzenhausen | 1 |
London | 1 |
Mountain View | 1 |
Philadelphia | 1 |
Plauen | 1 |
Saint Petersburg | 1 |
Scottsdale | 1 |
Seoul | 1 |
Seremban | 1 |
Sofia | 1 |
Stockholm | 1 |
Toronto | 1 |
Washington | 1 |
Zgierz | 1 |